An Observational, Retrospective, Single-arm, Open US and Israel Study , for Usability Assessment and Algorithm, Development of the Cordio HearO™ Systeam
Latest Information Update: 05 Jan 2025
Price :
$35 *
At a glance
- Drugs Nivolumab (Primary)
- Indications Body regions
- Focus Therapeutic Use
- 05 Jan 2025 Bundle created during tool testing
- 05 Jan 2025 New trial record